AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · Real-Time Price · USD
9.06
+0.22 (2.49%)
Aug 13, 2025, 4:00 PM - Market closed
AngioDynamics Stock Forecast
Stock Price Forecast
According to 3 professional analysts, the 12-month price target for AngioDynamics stock ranges from a low of $16 to a high of $24. The average analyst price target of $19 forecasts a 109.71% increase in the stock price over the next year.
Price Target: $19.00 (+109.71%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AngioDynamics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 2 | 2 | 2 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Initiates $24 | Strong Buy | Initiates | $24 | +164.90% | Jul 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +76.60% | Jul 16, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +87.64% | Jul 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $16 | Strong Buy | Maintains | $15 → $16 | +76.60% | Apr 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $14 → $15 | Strong Buy | Maintains | $14 → $15 | +65.56% | Jan 10, 2025 |
Financial Forecast
Revenue This Year
313.34M
from 292.50M
Increased by 7.13%
Revenue Next Year
333.02M
from 313.34M
Increased by 6.28%
EPS This Year
-0.23
from -0.83
EPS Next Year
0.09
from -0.23
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 324.1M | 345.8M | 372.1M | |
| Avg | 313.3M | 333.0M | 361.5M | |
| Low | 299.5M | 317.1M | 347.3M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 10.8% | 10.3% | 11.7% | |
| Avg | 7.1% | 6.3% | 8.5% | |
| Low | 2.4% | 1.2% | 4.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | -0.21 | 0.09 | 0.45 | |
| Avg | -0.23 | 0.09 | 0.44 | |
| Low | -0.27 | 0.09 | 0.42 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | - | - | 391.8% | |
| Avg | - | - | 377.8% | |
| Low | - | - | 359.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.